COVID-19 treatment | Gilead signs pact with Cipla, Jubilant and Hetero to manufacture, distribute Remdesivir in 127 countries

The licenses are royalty-free until the World Health Organization (WHO) declares the end of the Public Health Emergency of International Concern regarding COVID-19, or until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent COVID-19, whichever is earlier.

from Moneycontrol Latest News https://www.moneycontrol.com/news/business/covid-19-treatment-|-gilead-signs-pactcipla-jubilanthetero-to-manufacture-distribute-remdesivir127-countries_13767881.html